Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track focuses on the latest strategies and interventions for managing cardiometabolic diseases, including diabetes and obesity. Researchers will present innovative approaches that integrate lifestyle modifications and pharmacological treatments.
This session will explore the genetic and molecular underpinnings of various metabolic disorders, including inherited metabolic diseases. Emphasis will be placed on the role of gene therapy and molecular medicine in treatment strategies.
This track examines the interplay between inflammation and metabolic disorders, particularly in the context of cardiovascular health. Presentations will highlight recent findings on inflammatory pathways and their implications for disease management.
This session will delve into the impact of nutrition and dietary interventions on metabolic health and disease prevention. Researchers will share insights on how specific dietary patterns can influence metabolic responses and outcomes.
This track will focus on advancements in newborn screening techniques for early detection of metabolic disorders. Discussions will include the implications of early diagnosis on treatment outcomes and long-term health.
This session will cover the latest developments in the diagnosis and management of lysosomal storage disorders. Emphasis will be placed on the role of tandem mass spectrometry and emerging therapies in improving patient outcomes.
This track will investigate the complex relationship between obesity and metabolic disorders, including diabetes and cardiovascular diseases. Presentations will focus on pathophysiological mechanisms and innovative treatment approaches.
This session will explore the connections between endocrine disorders and metabolic health, with a focus on diabetes and thyroid dysfunction. Researchers will present findings on hormonal regulation and its implications for metabolic disease management.
This track will highlight novel therapeutic approaches for the treatment of diabetes and related metabolic disorders. Presentations will cover pharmacological innovations, lifestyle interventions, and their clinical implications.
This session will focus on the genetic factors contributing to cardiovascular and metabolic syndromes. Researchers will discuss the implications of genetic research for understanding disease mechanisms and developing targeted therapies.
This track will examine the role of the microbiome in influencing cardiovascular and metabolic health. Presentations will explore how microbial interactions can impact disease risk and treatment outcomes.